Prognosis of patients with vulnerable plaques indicated by coronary CT angiography

doi:10.3785/j.issn.1008-9292.2020.02.07

J Zhejiang Univ (Med Sci)

2020, Vol. 49

Issue (1): 76-81 DOI: 10.3785/j.issn.1008-9292.2020.02.07

Prognosis of patients with vulnerable plaques indicated by coronary CT angiography

LI Zhanlu(

),HUANG He,ZHANG Wenbin,WANG Min,FU Guosheng*(

)

Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China

Download:

HTML( 5 )

PDF(1434KB)
Export: BibTeX | EndNote (RIS)

Abstract

Objective: To investigate the prognosis of patients with vulnerable plaque indicated by coronary CT angiography (CCTA). Methods: Totally 1963 patients underwent CCTA from February 2nd 2015 to September 13th 2015, and 2728 coronary borderline lesions (stenosis of 50%-70%) were detected. Among them 804 patients had vulnerable plaques and 1159 patients had stable plaques. The primary endpoint was major cardiac adverse events (MACE), including cardiac death, acute myocardial infarction and target lesion revascularization. Results: Patients were followed up for a mean follow-up of 27.4±2.3 months. The incidence of MACE in the vulnerable plaque group was significantly higher than that in the stable plaque group (10.8%vs 2.3%, P < 0.01). After adjusting for age, gender, smoking, hypertension, diabetes, hyperlipidemia, the MACE hazard ratio (HR) in the vulnerable plaque group was 5.022 (95% CI:3.254-7.751, P < 0.01).Subgroup analysis showed that in the vulnerable plaque group, the incidence of MACE in patients taking antiplatelet and statin ≤3 months and those taking antiplatelet and statin > 3 months was 17.0%and 5.8%, respectively (HR=3.149, 95% CI:1.987-4.992, P < 0.01); but the difference did not seen in stable plaque group (HR=1.721, 95% CI:0.798-3.712, P>0.05). Conclusion: This study confirmed the risk of MACE in patients with vulnerable plaque detected by CCTA and the drug treatment may reduce the risk for patients with vulnerable plaque.

Key words： Coronary artery disease/diagnostic imaging Plaque, atherosclerotic Coronary angiography Tomography, X-ray computed Prognosis Follow-up studies

Received: 27 September 2019 Published: 08 June 2020

CLC:

R543.3

Corresponding Authors: FU Guosheng E-mail: alu511520@163.com;fugs@medmail.com.cn

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Zhanlu
	HUANG He
	ZHANG Wenbin
	WANG Min
	FU Guosheng

Cite this article:

LI Zhanlu,HUANG He,ZHANG Wenbin,WANG Min,FU Guosheng. Prognosis of patients with vulnerable plaques indicated by coronary CT angiography. J Zhejiang Univ (Med Sci), 2020, 49(1): 76-81.

URL:

http://www.zjujournals.com/med/10.3785/j.issn.1008-9292.2020.02.07 OR http://www.zjujournals.com/med/Y2020/V49/I1/76

冠状动脉CT血管造影提示临界病变有易损斑块患者预后分析

目的: 分析冠状动脉CT血管造影（CCTA）提示临界病变含有易损斑块患者的预后。方法: 回顾性分析2015年2月2日至9月13日在浙江大学医学院附属邵逸夫医院行CCTA检查提示为临界病变（直径狭窄50%~70%）且不需要介入治疗的患者1963例（2728处病变）。根据CCTA提示的斑块性质分为易损斑块组（804例）和稳定斑块组（1159例）。以发生主要不良心血管事件（MACE，包括心源性死亡、非致死性急性心肌梗死及靶病变血运重建）为观察终点，比较两组的预后。结果: 平均随访（27.4±2.3）个月，易损斑块组MACE发生率高于稳定斑块组（分别为10.8%和2.3%，P < 0.01），调整年龄、性别、吸烟、高血压病、糖尿病、高脂血症等进行多因素分析显示，易损斑块组发生MACE的风险比（HR）为5.022（95% CI：3.254~7.751，P < 0.01）。亚组分析提示，易损斑块未服药组（服用抗血小板及他汀类药物3个月及以下）和易损斑块服药组（服用抗血小板及他汀类药物3个月以上）MACE发生率分别为17.0%和5.8%，易损斑块未服药组发生MACE的风险增加（HR=3.149，95% CI：1.987~4.992，P < 0.01）；而稳定斑块组未观察到此差异（HR=1.721，95% CI：0.798~3.712，P>0.05）。结论: CCTA提示临界病变含有易损斑块的患者危险性更高，而药物治疗主要作用于易损斑块，对稳定斑块是否有效有待进一步讨论。

关键词： 冠状动脉疾病/影像诊断, 斑块, 动脉粥样硬化, 冠状血管造影术, 体层摄影术, X线计算机, 预后, 随访研究

Tab 1 Baseline characteristics of patients with vulnerable plaques or stable plaques

Tab 2 Coronary lesions of patients with vulnerable plaques or stable plaques

Fig 1 Major adverse cardiovascular event (MACE)-free survival curve for the vulnerable and stable plaque groups

Fig 2 Major adverse cardiovascular event (MACE)-free survival curves for the drug and drug-free groups


[1]	CONSTANTINIDES P . Plaque fissure in human coronary thrombosis[J]. J Atheroscler Res, 1966, 6 (3): 1- 17 doi: 10.1016/S0368-1319(66)80056-X

[2]	MULLER J E , ABELA G S , NESTOR W et al. Triggers, acute risk factors and vulnerable plaques:the lexicon of a new frontier[J]. J Am Coll Cardiol, 1994, 23 (3): 809- 813 doi: 10.1016/0735-1097(94)90772-2

[3]	LIBBY P . Coronary artery injury and the biology of atherosclerosis:inflammation, thrombosis, and stabilization[J]. Am J Cardiol, 2000, 86 (8B): 3J- 9J doi: 10.1016/s0002-9149(00)01339-4

[4]	SAJJADIEH A , HEKMATNIA A , KEIVANI M et al. Diagnostic performance of 64-row coronary CT angiography in detecting significant stenosis as compared with conventional invasive coronary angiography[J]. ARYA Atheroscler, 2013, 9 (2): 157- 163

[5]	MEIJBOOM W B , MEIJS M F , SCHUIJFJ D et al. Diagnostic accuracy of 64-slice computed tomography coronary angiography:a prospective, multicenter, multivendor study[J]. J Am Coll Cardiol, 2008, 52 (25): 2135- 2144 doi: 10.1016/j.jacc.2008.08.058

[6]	SCHMID M , PFLEDERER T , JANG I K et al. Relationship between degree of remodeling and CT attenuation of plaque in coronary atherosclerotic lesions:an in-vivo analysis by multi-detector computed tomography[J]. Atherosclerosis, 2008, 197 (1): 457- 464 doi: 10.1016/j.atherosclerosis.2007.07.003

[7]	VOROS S , RINEHART S , QIAN Z et al. Coronary atherosclerosis imaging by coronary CT angiography:current status, correlation with intravascular interrogation and meta-analysis[J]. JACC Cardiovasc Imaging, 2011, 4 (5): 537- 548 doi: 10.1016/j.jcmg.2011.03.006

[8]	GERSH B J , MARON B J , BONOW R O et al. 2011 ACCF/AHA Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy:executive summary[J]. Circulation, 2011, 124 (24): 2761- 2796 doi: 10.1161/CIR.0b013e318223e230

[9]	MOTOYAMA S , SARAI M , HARIGAYA H et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome[J]. J Am Coll Cardiol, 2009, 54 (1): 49- 57 doi: 10.1016/j.jacc.2009.02.068

[10]	PUCHNER S B , LIU T , MAYRHOFER T et al. High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain:results from the ROMICAT-II trial[J]. J Am Coll Cardiol, 2014, 64 (7): 684- 692 doi: 10.1016/j.jacc.2014.05.039

[11]	MAUROVICH-HORVAT P , FERENCIK M , VOROS S et al. Comprehensive plaque assessment by coronary CT angiography[J]. Nat Rev Cardiol, 2014, 11 (7): 390- 402 doi: 10.1038/nrcardio.2014.60

[12]	MINTZ G S , NISSEN S E , ANDERSONW D et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (ivus). A report of the american college of cardiology task force on clinical expert consensus documents[J]. J Am Coll Cardiol, 2001, 37 (5): 1478- 1492 doi: 10.1016/s0735-1097(01)01175-5

[13]	ACHENBACH S , ROPERS D , HOFFMANN U et al. Assessment of coronary remodeling in stenotic and nonstenotic coronary atherosclerotic lesions by multidetector spiral computed tomography[J]. J Am Coll Cardiol, 2004, 43 (5): 842- 847 doi: 10.1016/j.jacc.2003.09.053

[14]	MULLER J E , ABELA G S , NESTO R W et al. Triggers, acute risk factors and vulnerable plaques:the lexicon of a new frontier[J]. J Am Coll Cardiol, 1994, 23 (3): 809- 813 doi: 10.1016/0735-1097(94)90772-2

[15]	YONETSU T , JANG I K . Advances in intravascular imaging:new insights into the vulnerable plaque from imaging studies[J]. Korean Circ J, 2018, 48 (1): 1- 15 doi: 10.4070/kcj.2017.0182

[16]	KISHI S , GIANNOPOULOS A A , TANG A et al. Fractional flow reserve estimated at coronary CT angiography in intermediate lesions:comparison of diagnostic accuracy of different methods to determine coronary flow distribution[J]. Radiology, 2018, 287 (1): 76- 84 doi: 10.1148/radiol.2017162620

[17]	MAES F , JOLLY S S , CAIRNS J et al. Plaque sealing with drug-eluting stents versus medical therapy for treating intermediate non-obstructive saphenous vein graft lesions:a pooled analysis of the VELETI and VELETI Ⅱ trials[J]. J Invasive Cardiol, 2019, 31 (11): E308- E315

[18]	WATANABE H , ONISHI K , KAKEHI K et al. Clinical and angiographic factors predicting fractional flow reserve and explaining the visual-functional mismatch in patients with intermediate coronary artery stenosis[J]. Coron Artery Dis, 2020, 31 (1): 73- 80 doi: 10.1097/MCA.0000000000000817

[19]	YU M , LI W , LU Z et al. Quantitative baseline CT plaque characterization of unrevascularized non-culprit intermediate coronary stenosis predicts lesion volume progression and long-term prognosis:A serial CT follow-up study[J]. Int J Cardiol, 2018, 264:181- 186 doi: 10.1016/j.ijcard.2018.03.021

[20]	OTSUKA K , FUKUDA S , TANAKA A et al. Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome[J]. JACC Cardiovasc Imaging, 2013, 6 (4): 448- 457 doi: 10.1016/j.jcmg.2012.09.016

[21]	SANO K , KAWASAKI M , ISHIHARA Y et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound[J]. J Am Coll Cardiol, 2006, 47 (4): 734- 741 doi: 10.1016/j.jacc.2005.09.061

[22]	CALVERT P A , OBAID D R , O'SULLIVAN M et al. Association between IVUS findings and adverse outcomes in patients with coronary artery disease:the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study[J]. JACC Cardiovasc Imaging, 2011, 4 (8): 894- 901 doi: 10.1016/j.jcmg.2011.05.005

[23]	STONE G W , MAEHARA A , LANSKYA J et al. A prospective natural-history study of coronary atherosclerosis[J]. N Engl J Med, 2011, 364 (3): 226- 235 doi: 10.1056/NEJMoa1002358

[24]	LIBBY P , THEROUX P . Pathophysiology of coronary artery disease[J]. Circulation, 2005, 111 (25): 3481- 3488 doi: 10.1161/CIRCULATIONAHA.105.537878

[25]	VIRMANI R , KOLODGIE F D , BURKE A P et al. Lessons from sudden coronary death:a comprehensive morphological classification scheme for atherosclerotic lesions[J]. Arterioscler Thromb Vasc Biol, 2000, 20 (5): 1262- 1275 doi: 10.1161/01.atv.20.5.1262

[26]	ARBUSTINI E , DAL BELLO B , MORBINI P et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction[J]. Heart, 1999, 82 (3): 269- 272 doi: 10.1136/hrt.82.3.269

[1]	XU Chuncai,BAO Yingying,ZHU Jiajun,TENG Yanping,HE Yuanyuan,CHENG Ke,JI Fengjuan,WU Mingyuan. Remote monitoring of neonatal jaundice in newborns with ABO hemolytic disease[J]. J Zhejiang Univ (Med Sci), 2020, 49(5): 651-655.

[2]	MI Shuang,WU Yanjun,HONG Zhenghua,WANG Zhangfu,FENG Xingbing,ZHENG Guangbin. Expression of TLR4/MyD88/NF-κB pathway genes and its related inflammatory factors in secondary spinal cord injury[J]. J Zhejiang Univ (Med Sci), 2019, 48(6): 609-616.

[3]	WANG Yayun,CHEN Yuan,YANG Mengmeng,XI Fangfang,ZHAN Qitao,JIANG Ying,ZHAO Baihui,LUO Qiong. Prognosis of fetuses with cystichygroma and nuchal translucency/nuchal fold thickening on prenatal echography[J]. J Zhejiang Univ (Med Sci), 2019, 48(4): 434-438.

[4]	TONG Fan,YANG Rulai,LIU Chang,WU Dingwen,ZHANG Ting,HUANG Xinwen,HONG Fang,QIAN Guling,HUANG Xiaolei,ZHOU Xuelian,SHU Qiang,ZHAO Zhengyan. Screening for hereditary tyrosinemia and genotype analysis in newborns[J]. J Zhejiang Univ (Med Sci), 2019, 48(4): 459-464.

[5]	ZHONG Wansi, CHEN Zhicai, CHEN Hongfang, XU Dongjuan, WANG Zhimin, HU Haifang, WU Chenglong, ZHANG Xiaoling, MA Xiaodong, WANG Yaxian, HU Haitao, LOU Min, Improving In-hospital Stroke Service Utilisation (MISSION) in Zhejiang Province . Effects of emergency medical service on prognosis of ischemic stroke patients treated with intravenous thrombolysis[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 241-246.

[6]	CHEN Hongfang, GONG Xiaoxian, XU Dongjuan, WANG Zhimin, HU Haifang, WU Chenglong, ZHANG Xiaoling, MA Xiaodong, WANG Yaxian, HU Haitao, LOU Min, CHEN Zhicai, Improving In-hospital Stroke Service Utilisation (MISSION) in Zhejiang Province . Advanced treatment time improves outcomes of patients with ischemic stroke undergoing reperfusion therapy[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 247-253.

[7]	ZHANG Congcong, LOU Min, CHEN Zhicai, CHEN Hongfang, XU Dongjuan, WANG Zhimin, HU Haifang, WU Chenglong, ZHANG Xiaoling, MA Xiaodong, WANG Yaxian, HU Haitao, Improving In-hospital Stroke Service Utilisation (MISSION) in Zhejiang Province . Analysis of intravenous thrombolysis time and prognosis in patients with in-hospital stroke[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 260-266.

[8]	PAN Feihu, LOU Min, CHEN Zhicai, CHEN Hongfang, XU Dongjuan, WANG Zhimin, HU Haifang, WU Chenglong, ZHANG Xiaoling, MA Xiaodong, WANG Yaxian, HU Haitao, Improving In-hospital Stroke Service Utilisation (MISSION) in Zhejiang Province . Effect of different working time on the prognosis of ischemic stroke patients undergoing intravenous thrombolysis[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 267-274.

[9]	DU Dongfen,ZHU Lixia,WANG Yungui,YE XiujinG. Expression of WT1 gene and its prognostic value in patients with acute myeloid leukemia[J]. J Zhejiang Univ (Med Sci), 2019, 48(1): 50-57.

[10]	CHEN Qian,LIU Lu,ZHANG Jingjing,HAN Sai,CUI Baoxia,ZHANG Youzhong,KONG Beihua. Clinical features and prognosis of cervical adenocarcinoma and adenosquamous carcinoma: an analysis of 237 cases[J]. J Zhejiang Univ (Med Sci), 2018, 47(4): 357-361.

[11]	JIANG Yanqi,YANG Yalan,YANG Ting,LI Yueling,CHEN Liling,YAN Jin,YANG Yanfang. *Association of UCP2* rs659366 polymorphisms with the outcomes of patients after surgery for colorectal cancer**[J]. J Zhejiang Univ (Med Sci), 2018, 47(2): 143-149.

[12]	HUANG Bingxue,SANG Guoyao,TUO Xiaoqing,TIAN Tian,AbidanAiniwaer ,DAI Jianghong. Trajectory modeling for estimating the trend of human papillomavirus infection status among men who have sex with men[J]. J Zhejiang Univ (Med Sci), 2018, 47(2): 150-155.

[13]	LU Wei,LIN Mengna,ZHAO Shifang,WANG Huiming,HE Fuming. Application of modified lateral window for maxillary sinus floor augmentation[J]. J Zhejiang Univ (Med Sci), 2017, 46(6): 630-636.

[14]	DING Yuan,SUN Zhongquan,ZHANG Wenyan,ZHANG Xiangying,JIANG Yuancong,YAN Sheng,WANG Weilin. Application of enhanced recovery program in laparoscopic distal pancreatectomy[J]. J Zhejiang Univ (Med Sci), 2017, 46(6): 625-629.

[15]	PAN Yao, CHEN Jieyu, YU Risheng. Accurate imaging diagnosis and evaluation of pancreatic cancer[J]. J Zhejiang Univ (Med Sci), 2017, 46(5): 462-467.

Viewed

Full text

Abstract

Cited

Shared

Discussed